Chemours price target raised to $20 from $18 at BMO Capital

4 days ago 9

TipRanks

Tue, January 20, 2026 astatine 6:05 AM CST 1 min read

BMO Capital expert John McNulty raised the firm’s price target connected Chemours (CC) to $20 from $18 and keeps an Outperform standing connected the shares aft the institution sold its Taiwan TiO2 tract for $360M. The “sizable windfall” is simply a “meaningful positive” for Chemours, the expert tells investors successful a probe note. BMO expects the proceeds to spell toward indebtedness reduction, providing a “liquidity cushion” for aboriginal PFAS settlements. The steadfast says the merchantability should assistance investors “get comfortable” that Chemours has capable currency to money aboriginal maturation opportunities going forward.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected CC:

Disclaimer & DisclosureReport an Issue

Chemours terms people raised to $18 from $16 astatine RBC Capital
Chemours to Sell Taiwan Site Land, Reduce Debt
Chemours agrees to merchantability erstwhile titanium dioxide tract successful Taiwan
Chemours terms people lowered to $13 from $15 astatine JPMorgan

Read Entire Article